Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting Blog Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…Certara2025 年 9 月 5 日
ToxStudio®: In silico tools to accelerate toxicology assessments Webinar ToxStudio®: In silico tools to accelerate toxicology assessments Certara2025 年 8 月 19 日
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…Certara2025 年 8 月 13 日
Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Blog 在药物开发中,用基于模型的浓度-QTc(C-QTc)分析取代传统 TQT 研究,以评估心血管安全性 Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…Certara2025 年 8 月 6 日
De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator Webinar 临床试验中降低 DDI 管理风险:介绍 DIDB 联合用药导航工具 Certara2025 年 8 月 5 日
Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling On-Demand Webinar 无动物实验的洞察:利用人源化芯片与 PBPK 建模 Certara2025 年 7 月 29 日
The Medicine Maker: The Biosimulation Generation Press Coverage 药物制造者:生物模拟时代 The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…Danielle Pillsbury2025 年 7 月 1 日
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning Publication 建模与模拟及真实世界证据在临床试验多样性规划中的关键作用:挑战应对策略 Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…Danielle Pillsbury2025 年 6 月 19 日
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara On-Demand Webinar 从数据到决策:基于模型的荟萃分析(MBMA)与 GSK 和 Certara 真实世界影响 Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…Certara2025 年 6 月 18 日
常见体外药物相互作用研究缺陷有哪些? 博客 常见体外药物相互作用研究缺陷有哪些? Certara drug interaction science experts share data and experimental design gaps commonly found in in…Certara2025 年 6 月 9 日